Marinella Roberti - Publications

Affiliations: 
FaBiT Università di Bologna, Bologna, Italy 
Area:
Medicinal Chemistry

71 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Bagnolini G, Milano D, Manerba M, Schipani F, Ortega JA, Gioia D, Falchi F, Balboni A, Farabegoli F, De Franco F, Robertson J, Pellicciari R, Pallavicini I, Peri S, Minucci S, ... ... Roberti M, et al. Synthetic lethality in pancreatic cancer: discovery of a new RAD51-BRCA2 small molecule disruptor that inhibits homologous recombination and synergizes with olaparib. Journal of Medicinal Chemistry. PMID 32037829 DOI: 10.1021/Acs.Jmedchem.9B01526  0.557
2020 Linciano P, Cullia G, Borsari C, Santucci M, Ferrari S, Witt G, Gul S, Kuzikov M, Ellinger B, Santarém N, Cordeiro da Silva A, Conti P, Bolognesi ML, Roberti M, Prati F, et al. Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaign. European Journal of Medicinal Chemistry. 189: 112047. PMID 31982652 DOI: 10.1016/J.Ejmech.2020.112047  0.446
2019 Roberti M, Schipani F, Bagnolini G, Milano D, Giacomini E, Falchi F, Balboni A, Manerba M, Farabegoli F, De Franco F, Robertson J, Minucci S, Pallavicini I, Di Stefano G, Girotto S, et al. Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells. European Journal of Medicinal Chemistry. 165: 80-92. PMID 30660828 DOI: 10.1016/J.Ejmech.2019.01.008  0.532
2018 Uliassi E, Peña-Altamira LE, Morales AV, Massenzio F, Petralla S, Rossi M, Roberti M, Martínez-González L, Martínez A, Monti B, Bolognesi ML. A focused library of psychotropic analogs with neuroprotective and neuroregenerative potential. Acs Chemical Neuroscience. PMID 30253086 DOI: 10.1021/Acschemneuro.8B00242  0.391
2018 Porru E, Franco P, Calabria D, Spinozzi S, Roberti M, Caliceti C, Roda A. Combined analytical approaches to define biodistribution and biological activity of semi-synthetic berberrubine, the active metabolite of natural berberine. Analytical and Bioanalytical Chemistry. PMID 29411090 DOI: 10.1007/S00216-018-0884-2  0.326
2017 Bruno F, Castelli G, Vitale F, Giacomini E, Roberti M, Colomba C, Cascio A, Tolomeo M. Effects of trans-stilbene and terphenyl compounds on different strains of Leishmania and on cytokines production from infected macrophages. Experimental Parasitology. PMID 29154845 DOI: 10.1016/J.Exppara.2017.11.004  0.301
2017 Falchi F, Giacomini E, Masini T, Boutard N, Di Ianni L, Manerba M, Farabegoli F, Rossini L, Robertson J, Minucci S, Pallavicini I, Di Stefano G, Pellicciari R, Roberti M, Cavalli A. Synthetic lethality triggered by combining Olaparib with BRCA2-Rad51 disruptors. Acs Chemical Biology. PMID 28841282 DOI: 10.1021/Acschembio.7B00707  0.551
2017 Manerba M, Di Ianni L, Govoni M, Roberti M, Recanatini M, Di Stefano G. LDH inhibition impacts on heat shock response and induces senescence of hepatocellular carcinoma cells. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 105: 91-98. PMID 28501492 DOI: 10.1016/J.Ejps.2017.05.015  0.35
2016 Jeřábek J, Uliassi E, Guidotti L, Korábečný J, Soukup O, Sepsova V, Hrabinova M, Kuča K, Bartolini M, Peña-Altamira LE, Petralla S, Monti B, Roberti M, Bolognesi ML. Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease. European Journal of Medicinal Chemistry. 127: 250-262. PMID 28064079 DOI: 10.1016/J.Ejmech.2016.12.048  0.358
2016 Rupiani S, Guidotti L, Manerba M, Ianni LD, Giacomini E, Falchi F, Stefano GD, Roberti M, Recanatini M. Synthesis of natural urolithin M6, a galloflavin mimetic, as a potential inhibitor of lactate dehydrogenase A. Organic & Biomolecular Chemistry. PMID 27827510 DOI: 10.1039/C6Ob01977C  0.734
2016 Manerba M, Di Ianni L, Govoni M, Roberti M, Recanatini M, Di Stefano G. Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. PMID 27622920 DOI: 10.1016/J.Ejps.2016.09.014  0.385
2016 Giacomini E, Rupiani S, Guidotti L, Recanatini M, Roberti M. The Use of Stilbene Scaffold in Medicinal Chemistry and Multi-Target Drug Design. Current Medicinal Chemistry. PMID 27183980 DOI: 10.2174/0929867323666160517121629  0.727
2016 Garuti L, Roberti M, Bottegoni G, Ferraro M. Diaryl Urea: a Privileged Structure in Anticancer Agents. Current Medicinal Chemistry. PMID 27063259 DOI: 10.2174/0929867323666160411142532  0.425
2016 Castelli G, Bruno F, Vitale F, Roberti M, Colomba C, Giacomini E, Guidotti L, Cascio A, Tolomeo M. In vitro Antileishmanial Activity of trans-Stilbene and Terphenyl Compounds. Experimental Parasitology. PMID 26953250 DOI: 10.1016/J.Exppara.2016.03.007  0.424
2015 Rupiani S, Buonfiglio R, Manerba M, Di Ianni L, Vettraino M, Giacomini E, Masetti M, Falchi F, Di Stefano G, Roberti M, Recanatini M. Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors. European Journal of Medicinal Chemistry. 101: 63-70. PMID 26114812 DOI: 10.1016/J.Ejmech.2015.06.028  0.75
2015 Manerba M, Di Ianni L, Fiume L, Roberti M, Recanatini M, Di Stefano G. Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 74: 95-102. PMID 25930121 DOI: 10.1016/J.Ejps.2015.04.022  0.406
2015 Giacomini E, Buonfiglio R, Masetti M, Wang Y, Tseng GN, Roberti M, Recanatini M. A ligand-based virtual screening approach to identify small molecules as HERG channel activators. Combinatorial Chemistry & High Throughput Screening. 18: 269-80. PMID 25747449 DOI: 10.2174/1386207318666150305121841  0.389
2015 Garuti L, Roberti M, Bottegoni G. Multi-kinase inhibitors. Current Medicinal Chemistry. 22: 695-712. PMID 25511779 DOI: 10.2174/0929867321666141216125528  0.397
2015 Rupiani S, Buonfiglio R, Manerba M, Di Ianni L, Vettraino M, Giacomini E, Masetti M, Falchi F, Di Stefano G, Roberti M, Recanatini M. Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors European Journal of Medicinal Chemistry. 101: 63-70. DOI: 10.1016/j.ejmech.2015.06.028  0.717
2014 Nepovimova E, Uliassi E, Korabecny J, Peña-Altamira LE, Samez S, Pesaresi A, Garcia GE, Bartolini M, Andrisano V, Bergamini C, Fato R, Lamba D, Roberti M, Kuca K, Monti B, et al. Multitarget drug design strategy: Quinone-tacrine hybrids designed to block amyloid-β aggregation and to exert anticholinesterase and antioxidant effects Journal of Medicinal Chemistry. 57: 8576-8589. PMID 25259726 DOI: 10.1021/Jm5010804  0.379
2014 Giacomini E, Nebbioso A, Ciotta A, Ianni C, Falchi F, Roberti M, Tolomeo M, Grimaudo S, Cristina AD, Pipitone RM, Altucci L, Recanatini M. Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activity. Acs Medicinal Chemistry Letters. 5: 973-8. PMID 25221651 DOI: 10.1021/Ml5000959  0.469
2014 Spinozzi S, Colliva C, Camborata C, Roberti M, Ianni C, Neri F, Calvarese C, Lisotti A, Mazzella G, Roda A. Berberine and its metabolites: Relationship between physicochemical properties and plasma levels after administration to human subjects Journal of Natural Products. 77: 766-772. PMID 24593257 DOI: 10.1021/Np400607K  0.305
2014 Garuti L, Roberti M, Bottegoni G. Benzimidazole derivatives as kinase inhibitors Current Medicinal Chemistry. 21: 2284-2298. PMID 24533813 DOI: 10.2174/0929867321666140217105714  0.39
2013 Turroni S, Tolomeo M, Mamone G, Picariello G, Giacomini E, Brigidi P, Roberti M, Grimaudo S, Pipitone RM, Di Cristina A, Recanatini M. A Natural-Like Synthetic Small Molecule Impairs Bcr-Abl Signaling Cascades and Induces Megakaryocyte Differentiation in Erythroleukemia Cells Plos One. 8. PMID 23460890 DOI: 10.1371/Journal.Pone.0057650  0.361
2013 Tolomeo M, Roberti M, Scapozza L, Tarantelli C, Giacomini E, Titone L, Saporito L, Di Carlo P, Colomba C. TTAS a new stilbene derivative that induces apoptosis in Leishmania infantum Experimental Parasitology. 133: 37-43. PMID 23103597 DOI: 10.1016/J.Exppara.2012.10.006  0.408
2012 Farabegoli F, Vettraino M, Manerba M, Fiume L, Roberti M, Di Stefano G. Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways European Journal of Pharmaceutical Sciences. 47: 729-738. PMID 22954722 DOI: 10.1016/J.Ejps.2012.08.012  0.36
2012 Cavalli A, Buonfiglio R, Ianni C, Masetti M, Ceccarini L, Caves R, Chang MWY, Mitcheson JS, Roberti M, Recanatini M. Computational design and discovery of "minimally structured" hERG blockers Journal of Medicinal Chemistry. 55: 4010-4014. PMID 22455383 DOI: 10.1021/Jm201194Q  0.378
2012 Chiriano G, De Simone A, Mancini F, Perez DI, Cavalli A, Bolognesi ML, Legname G, Martinez A, Andrisano V, Carloni P, Roberti M. A small chemical library of 2-aminoimidazole derivatives as BACE-1 inhibitors: Structure-based design, synthesis, and biological evaluation. European Journal of Medicinal Chemistry. 48: 206-13. PMID 22209418 DOI: 10.1016/J.Ejmech.2011.12.016  0.443
2012 Manerba M, Vettraino M, Fiume L, di Stefano G, Sartini A, Giacomini E, Buonfiglio R, Roberti M, Recanatini M. Galloflavin (CAS 568-80-9): A Novel Inhibitor of Lactate Dehydrogenase Chemmedchem. 7: 311-317. PMID 22052811 DOI: 10.1002/Cmdc.201100471  0.431
2011 Garuti L, Roberti M, Bottegoni G. Irreversible protein kinase inhibitors Current Medicinal Chemistry. 18: 2981-2994. PMID 21651479 DOI: 10.2174/092986711796391705  0.425
2011 Chiriano G, Sartini A, Mancini F, Andrisano V, Bolognesi ML, Roberti M, Recanatini M, Carloni P, Cavalli A. Sequential virtual screening approach to the identification of small organic molecules as potential BACE-1 inhibitors. Chemical Biology & Drug Design. 77: 268-71. PMID 21244641 DOI: 10.1111/J.1747-0285.2011.01087.X  0.374
2010 Bongarzone S, Tran HNA, Cavalli A, Roberti M, Carloni P, Legname G, Bolognesi ML. Parallel synthesis, evaluation, and preliminary structure-activity relationship of 2,5-diamino-1,4-benzoquinones as a novel class of bivalent anti-prion compound Journal of Medicinal Chemistry. 53: 8197-8201. PMID 21047125 DOI: 10.1021/Jm100882T  0.394
2010 Garuti L, Roberti M, Bottegoni G. Non-ATP competitive protein kinase inhibitors Current Medicinal Chemistry. 17: 2804-2821. PMID 20586715 DOI: 10.2174/092986710791859333  0.358
2010 Roberti M, Natalini B, Andrisano V, Seraglia R, Gioiello A, Pellicciari R. Thermal and catalytic reactions of ethyl diazopyruvate with [60]fullerene Tetrahedron. 66: 7329-7332. DOI: 10.1016/J.Tet.2010.06.067  0.473
2009 Pizzirani D, Roberti M, Grimaudo S, Di Cristina A, Pipitone RM, Tolomeo M, Recanatini M. Identification of biphenyl-based hybrid molecules able to decrease the intracellular level of Bcl-2 protein in Bcl-2 overexpressing leukemia cells Journal of Medicinal Chemistry. 52: 6936-6940. PMID 19764793 DOI: 10.1021/Jm900907S  0.426
2009 Garuti L, Roberti M, Bottegoni G. Small molecule Aurora kinases inhibitors Current Medicinal Chemistry. 16: 1949-1963. PMID 19519375 DOI: 10.2174/092986709788682227  0.424
2008 Garuti L, Roberti M, Pizzirani D. Synthetic small molecule Cdc25 phosphatases inhibitors Current Medicinal Chemistry. 15: 573-580. PMID 18336271 DOI: 10.2174/092986708783769722  0.496
2008 Pizzirani D, Roberti M, Cavalli A, Grimaudo S, Di Cristina A, Pipitone RM, Gebbia N, Tolomeo M, Recanatini M. Antiproliferative agents that interfere with the cell cycle at the G 1→S transition: Further development and characterization of a small library of stilbene-derived compounds Chemmedchem. 3: 345-355. PMID 18161738 DOI: 10.1002/Cmdc.200700258  0.442
2007 Garuti L, Roberti M, Pizzirani D. Nitrogen-containing heterocyclic quinones: A class of potential selective antitumor agents Mini-Reviews in Medicinal Chemistry. 7: 481-489. PMID 17504183 DOI: 10.2174/138955707780619626  0.404
2007 Kaur G, Roberti M, Raul F, Pendurthi UR. Suppression of human monocyte tissue factor induction by red wine phenolics and synthetic derivatives of resveratrol. Thrombosis Research. 119: 247-56. PMID 16507316 DOI: 10.1016/J.Thromres.2006.01.020  0.356
2007 Pizzirani D, Roberti M, Recanatini M. Domino Knoevenagel/Diels-Alder sequence coupled to Suzuki reaction: a valuable synthetic platform for chemical biology Tetrahedron Letters. 48: 7120-7124. DOI: 10.1016/J.Tetlet.2007.07.214  0.301
2006 Roberti M, Pizzirani D, Recanatini M, Simoni D, Grimaudo S, Di Cristina A, Abbadessa V, Gebbia N, Tolomeo M. Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells. Journal of Medicinal Chemistry. 49: 3012-8. PMID 16686543 DOI: 10.1021/Jm060253O  0.361
2006 Simoni D, Roberti M, Invidiata FP, Aiello E, Aiello S, Marchetti P, Baruchello R, Eleopra M, Di Cristina A, Grimaudo S, Gebbia N, Crosta L, Dieli F, Tolomeo M. Stilbene-based anticancer agents: resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism. Bioorganic & Medicinal Chemistry Letters. 16: 3245-8. PMID 16580204 DOI: 10.1016/J.Bmcl.2006.03.028  0.379
2005 Simoni D, Giannini G, Roberti M, Rondanin R, Baruchello R, Rossi M, Grisolia G, Invidiata FP, Aiello S, Marino S, Cavallini S, Siniscalchi A, Gebbia N, Crosta L, Grimaudo S, et al. Studies on the apoptotic activity of natural and synthetic retinoids: discovery of a new class of synthetic terphenyls that potently support cell growth and inhibit apoptosis in neuronal and HL-60 cells. Journal of Medicinal Chemistry. 48: 4293-9. PMID 15974583 DOI: 10.1021/Jm049080Y  0.382
2005 Tolomeo M, Grimaudo S, Di Cristina A, Roberti M, Pizzirani D, Meli M, Dusonchet L, Gebbia N, Abbadessa V, Crosta L, Barucchello R, Grisolia G, Invidiata F, Simoni D. Pterostilbene and 3'-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells. The International Journal of Biochemistry & Cell Biology. 37: 1709-26. PMID 15878840 DOI: 10.1016/J.Biocel.2005.03.004  0.379
2005 Simoni D, Rossi M, Bertolasi V, Roberti M, Pizzirani D, Rondanin R, Baruchello R, Invidiata FP, Tolomeo M, Grimaudo S, Merighi S, Varani K, Gessi S, Borea PA, Marino S, et al. Synthesis and pharmacology of 6-substituted benztropines: discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter. Journal of Medicinal Chemistry. 48: 3337-43. PMID 15857139 DOI: 10.1021/Jm0490235  0.318
2005 Simoni D, Grisolia G, Giannini G, Roberti M, Rondanin R, Piccagli L, Baruchello R, Rossi M, Romagnoli R, Invidiata FP, Grimaudo S, Jung MK, Hamel E, Gebbia N, Crosta L, et al. Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines. Journal of Medicinal Chemistry. 48: 723-36. PMID 15689156 DOI: 10.1021/Jm049622B  0.37
2005 Grimaudo S, Di Cristina A, Abbadessa V, Daniele S, Roberti M, Tolomeo M. Novel Stilbene-Based Antileukemic Agents Active in P-Glycoprotein Expressing and Apoptosis-Resistant Acute Leukaemia Cell Lines. Blood. 106: 4436-4436. DOI: 10.1182/Blood.V106.11.4436.4436  0.428
2004 Chatgilialoglu C, Ferreri C, Gimisis T, Roberti M, Balzarini J, De Clercq E. Synthesis and biological evaluation of novel 1'-branched and spironucleoside analogues. Nucleosides, Nucleotides & Nucleic Acids. 23: 1565-81. PMID 15620096 DOI: 10.1081/Ncn-200031391  0.428
2004 Garuti L, Roberti M, Pizzirani D, Pession A, Leoncini E, Cenci V, Hrelia S. Differential antiproliferative activity of new benzimidazole-4,7-diones. Farmaco (Società Chimica Italiana : 1989). 59: 663-8. PMID 15262537 DOI: 10.1016/J.Farmac.2004.04.001  0.406
2003 Roberti M, Pizzirani D, Simoni D, Rondanin R, Baruchello R, Bonora C, Buscemi F, Grimaudo S, Tolomeo M. Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents. Journal of Medicinal Chemistry. 46: 3546-54. PMID 12877593 DOI: 10.1021/Jm030785U  0.419
2002 Garuti L, Roberti M, De Clercq E. Synthesis and antiviral/antiproliferative activity of some N-sulphonylbenzimidazoles. Bioorganic & Medicinal Chemistry Letters. 12: 2707-10. PMID 12217359 DOI: 10.1016/S0960-894X(02)00535-8  0.421
2001 Garuti L, Roberti M, Gentilomi G. Synthesis and antiviral assays of some benzimidazole nucleosides and acyclonucleosides Farmaco. 56: 815-819. PMID 11765032 DOI: 10.1016/S0014-827X(01)01164-8  0.382
2001 Garuti L, Roberti M, Pession A, Leoncini E, Hrelia S. Synthesis and antiproliferative activity of some thiazolylbenzimidazole-4,7-diones Bioorganic and Medicinal Chemistry Letters. 11: 3147-3149. PMID 11720862 DOI: 10.1016/S0960-894X(01)00639-4  0.389
2001 Simoni D, Roberti M, Invidiata FP, Rondanin R, Baruchello R, Malagutti C, Mazzali A, Rossi M, Grimaudo S, Capone F, Dusonchet L, Meli M, Raimondi MV, Landino M, D'Alessandro N, et al. Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells Journal of Medicinal Chemistry. 44: 2308-2318. PMID 11428925 DOI: 10.1021/Jm0010320  0.384
2001 Simoni D, Roberti M, Rondanin R, Baruchello R, Rossi M, Invidiata FP, Merighi S, Varani K, Gessi S, Borea PA, Marino S, Cavallini S, Bianchi C, Siniscalchi A. Effects of two-carbon bridge region methoxylation of benztropine: Discovery of novel chiral ligands for the dopamine transporter Bioorganic and Medicinal Chemistry Letters. 11: 823-827. PMID 11277529 DOI: 10.1016/S0960-894X(01)00068-3  0.302
2001 Simoni D, Rondanin R, Baruchello R, Roberti M, Rossi M, Grimaudo S, D'Alessandro N, Invidiata FP, Tolomeo M. Retinoic acid and analogs as potent inducers of differentiation and apoptosis. New promising chemopreventive and chemotherapeutic agents in oncology Pure and Applied Chemistry. 73: 1437-1444. DOI: 10.1351/Pac200173091437  0.418
2000 Simoni D, Roberti M, Paolo Invidiata F, Rondanin R, Baruchello R, Malagutti C, Mazzali A, Rossi M, Grimaudo S, Dusonchet L, Meli M, Raimondi MV, D'Alessandro N, Tolomeo M. Programmed cell death (PCD) associated with the stilbene motif of arotinoids: Discovery of novel apoptosis inducer agents possessing activity on multidrug resistant tumor cells Bioorganic and Medicinal Chemistry Letters. 10: 2669-2673. PMID 11128648 DOI: 10.1016/S0960-894X(00)00547-3  0.378
2000 Garuti L, Roberti M, Malagoli M, Rossi T, Castelli M. Synthesis and antiproliferative activity of some benzimidazole-4,7-dione derivatives Bioorganic and Medicinal Chemistry Letters. 10: 2193-2195. PMID 11012027 DOI: 10.1016/S0960-894X(00)00429-7  0.401
2000 Garuti L, Roberti M, Gentilomi G. Synthesis and antiviral assays of some 2-substituted benzimidazole-N- carbamates Farmaco. 55: 35-39. PMID 10755229 DOI: 10.1016/S0014-827X(99)00117-2  0.384
2000 Roberti M, Rondanin R, Ferroni R, Baruchello R, Invidiata FP, Andrisano V, Bertucci C, Bertolasi V, Grimaudo S, Tolomeo M, Simoni D. Pig liver esterase (PLE)-mediated resolution of N-substituted 4-benzoyloxy-3-carbomethoxypiperidines: A convenient preparation of 4-hydroxy- and 4-benzoyloxy-3-carbomethoxypiperidines in enantiomerically pure form Tetrahedron Asymmetry. 11: 4397-4405. DOI: 10.1016/S0957-4166(00)00404-3  0.323
1999 Garuti L, Roberti M, Cermelli C. Synthesis and antiviral activity of some N-benzenesulphonylbenzimidazoles Bioorganic and Medicinal Chemistry Letters. 9: 2525-2530. PMID 10498201 DOI: 10.1016/S0960-894X(99)00429-1  0.365
1999 Simoni D, Roberti M, Andrisano V, Manferdini M, Rondanin R, Invidiata FP. Two-carbon bridge substituted cocaines: Enantioselective synthesis, attribution of the absolute configuration and biological activity of novel 6- and 7-methoxylated cocaines Farmaco. 54: 275-287. PMID 10418122 DOI: 10.1016/S0014-827X(99)00027-0  0.336
1999 Kozikowski AP, Simoni D, Roberti M, Rondanin R, Wang S, Du P, Johnson KM. Synthesis of 8-Oxa analogues of norcocaine endowed with interesting cocaine-like activity. Bioorganic & Medicinal Chemistry Letters. 9: 1831-6. PMID 10406650 DOI: 10.1016/S0960-894X(99)00273-5  0.477
1999 Simoni D, Roberti M, Rondanin R, Kozikowski AP. Enantioselective deprotonation of the 8-oxabicyclo[3.2.1]octan-3-one: Synthesis of 8-oxa-norcocaines and 8-oxa-pseudonorcocaines Tetrahedron Letters. 40: 4425-4428. DOI: 10.1016/S0040-4039(99)00763-7  0.488
1998 Garuti L, Roberti M, Rossi T, Castelli M, Malagoli M. Synthesis and antiproliferative activity of 3-substituted 1H-indole [3,2-d]-l,2,3-triazin-4 (3H)-ones European Journal of Medicinal Chemistry. 33: 43-46. DOI: 10.1016/S0223-5234(99)80074-9  0.372
1996 Kozikowski AP, Simoni D, Manfredini S, Roberti M, Stoelwinder J. Synthesis of the 6- and 7-hydroxylated cocaines and pseudococaines Tetrahedron Letters. 37: 5333-5336. DOI: 10.1016/0040-4039(96)01123-9  0.465
1995 Garuti L, Roberti M, Rossi M, Giovanninetti G. Some new 3-methoxy-5-methyl-1,4-substituted pyrazoles Farmaco. 50: 815-818. PMID 8593179  0.309
1993 Pellicciari R, Natalini B, Costantino G, Garzon A, Luneia R, Mahmoud MR, Marinozzi M, Roberti M, Rosato GC, Shiba SA. Heterocyclic modulators of the NMDA receptor. Farmaco (Societã  Chimica Italiana : 1989). 48: 151-7. PMID 8494596  0.405
1992 Kozikowski AP, Roberti M, Xiang L, Bergmann JS, Callahan PM, Cunningham KA, Johnson KM. Structure-activity relationship studies of cocaine: replacement of the C-2 ester group by vinyl argues against H-bonding and provides an esterase-resistant, high-affinity cocaine analogue. Journal of Medicinal Chemistry. 35: 4764-6. PMID 1469704 DOI: 10.1021/Jm00103A015  0.395
1992 Baraldi PG, Budriesi R, Cacciari B, Chiarini A, Garuti L, Giovanninetti G, Leoni A, Roberti M. Synthesis and Calcium Antagonist Activity of Dialkyl 1,4-Dihydro-2,6-dimethyl-4-(nitrogenous heteroaryl)-3,5-pyridine Dicarboxylates Collection of Czechoslovak Chemical Communications. 57: 169-178. DOI: 10.1135/Cccc19920169  0.356
Show low-probability matches.